Anzeige
Mehr »
Login
Donnerstag, 04.03.2021 Börsentäglich über 12.000 News von 657 internationalen Medien
Übernahme-News! Relay Medical im Fokus der Anleger!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 918846 ISIN: CA4229101098 Ticker-Symbol: HBP 
Frankfurt
03.03.21
19:50 Uhr
0,565 Euro
-0,015
-2,59 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
HELIX BIOPHARMA CORP Chart 1 Jahr
5-Tage-Chart
HELIX BIOPHARMA CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,5200,60503.03.

Aktuelle News zur HELIX BIOPHARMA Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
29.01.Helix BioPharma Corp: Helix BioPharma shareholders approve AGM resolutions11
28.01.Helix BioPharma Corp.: Helix Biopharma Corp. Reports Voting Results217RICHMOND HILL, ON / ACCESSWIRE / January 28, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of...
► Artikel lesen
13.01.Helix BioPharma Corp: Helix BioPharma does not say why stock is up15
HELIX BIOPHARMA Aktie jetzt für 0€ handeln
13.01.Helix BioPharma Corp.: Helix Biopharma Corp. Responds to Market Activity241 RICHMOND HILL, ON / ACCESSWIRE / January 13, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of...
► Artikel lesen
30.12.20Helix BioPharma Corp: Helix BioPharma closes $3-million financing3
30.12.20Helix BioPharma Corp. Closes Private Placement313RICHMOND HILL, ON / ACCESSWIRE / December 30, 2020 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of...
► Artikel lesen
22.12.20Helix BioPharma Corp: Helix BioPharma closes Polish subsidiary sale to CAIAC1
22.12.20Helix BioPharma Corp. Finalizes Polish Subsidiary Divestiture258RICHMOND HILL, ON / ACCESSWIRE / December 22, 2020 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of...
► Artikel lesen
16.12.20Helix Biopharma reports FQ1 results2
16.12.20Helix BioPharma Corp: Helix BioPharma spends $1.08M on R&D in Q1 FY 20211
16.12.20Helix BioPharma Corp.: Helix Biopharma Corp. Announces Fiscal 2021 First Quarter Results263RICHMOND HILL, ON / ACCESSWIRE / December 15, 2020 / Helix BioPharma Corp. (TSX:HBP), ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field...
► Artikel lesen
05.12.20Helix BioPharma Corp: Helix BioPharma closes private placement for $1.1M5
05.12.20Helix BioPharma Corp. Closes Private Placement412RICHMOND HILL, ON / ACCESSWIRE / December 4, 2020 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of...
► Artikel lesen
09.11.20Helix BioPharma Corp: Helix signs definitive agreement for subsidiary sale6
09.11.20Helix BioPharma Corp. Signs Definitive Agreement to Fully Divest Polish Subsidiary392RICHMOND HILL, ON / ACCESSWIRE / November 9, 2020 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of...
► Artikel lesen
29.10.20Helix BioPharma reports FY results5
29.10.20Helix BioPharma Corp: Helix BioPharma spends $5.86M on R&D in fiscal 20202
29.10.20Helix BioPharma Corp. Announced Fiscal 2020 Year-End Results291RICHMOND HILL, ON / ACCESSWIRE / October 29, 2020 / Helix BioPharma Corp. (TSX:HBP), ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of...
► Artikel lesen
30.09.20Helix BioPharma Corp: Helix BioPharma extends closing date to sell Polish div3
30.09.20Helix BioPharma Corp.: Helix Biopharma Corp. Provides Polish Subsidiary Divestiture Update293RICHMOND HILL, ON / ACCESSWIRE / September 30, 2020 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field...
► Artikel lesen
Seite:  Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1